DONALD BROWER: Open Payments
NPI 1114998655 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 14 payments from 9 companies in 2025. Trend: 2023 $56 · 2024 $212 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $114 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $62 |
| Abbott Laboratories | 2 | $48 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
| PFIZER INC. | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Medtronic, Inc. | 1 | $17 |
Products named: General - Therapies, LifeVest, FUROSCIX, PERCLOSE PROSTYLE, MITRACLIP, ELIQUIS, Attruby, CAMZYOS.
Industry payments across IN — which companies pay providers there.
